Through microarray and expression studies, we identified FASTKD2 (Fas Activated Serine-Threonine Kinase Domains 2) as the pro-apoptotic target gene that is repressed by DIF-1 in breast cancer cells but not other cell types [5]. This evidence concerns the gene FASTKD2 and breast carcinoma.